J. Ryman

The Development of Methods to Account for Physiologic Dynamic Changes and Their Effects on the Pharmacokinetics of Therapeutic Monoclonal Antibodies and other Therapeutics

J. Ryman, 2017 .

Pharmacokinetics of Monoclonal Antibodies

B. Meibohm, J. Ryman, 2017, CPT: pharmacometrics & systems pharmacology.

Predicting effectiveness of the V114 vaccine against invasive pneumococcal disease in children

K. Yee, J. Sachs, J. Ryman, 2022, Expert review of vaccines.

Predicting vaccine effectiveness against invasive pneumococcal disease in children using immunogenicity data

K. Yee, J. Sachs, D. Weinberger, 2022, npj Vaccines.

Pharmacokinetics of ponazuril after oral administration to healthy llamas (Lama glama).

B. Meibohm, M. E. Prado, M. Boileau, 2011, American journal of veterinary research.

Comparison of Titer and Signal to Noise (S/N) for Determination of Anti-drug Antibody Magnitude Using Clinical Data from an Industry Consortium

V. Devanarayan, V. Jawa, J. Mora, 2022, The AAPS Journal.

Preclinical Evaluation of Inhalational Spectinamide-1599 Therapy against Tuberculosis.

B. Meibohm, M. Braunstein, C. Daley, 2021, ACS infectious diseases.

Immune Suppression During Preclinical Drug Development Mitigates Immunogenicity-Mediated Impact on Therapeutic Exposure

B. Meibohm, N. Chirmule, V. Jawa, 2017, The AAPS Journal.